Steven Marotta
Stock Analyst at CL King
(0.56)
# 3,930
Out of 4,876 analysts
15
Total ratings
37.5%
Success rate
-15.08%
Average return
Main Sectors:
Stocks Rated by Steven Marotta
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $22.34 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $24.56 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $28 | $3.54 | +690.96% | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | $32 → $41 | $13.53 | +203.03% | 3 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | $29 | $12.54 | +131.26% | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $103.02 | - | 3 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $20.75 | - | 4 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $22.34
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $24.56
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: $28
Current: $3.54
Upside: +690.96%
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: $32 → $41
Current: $13.53
Upside: +203.03%
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: $29
Current: $12.54
Upside: +131.26%
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $103.02
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $20.75
Upside: -